{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T16:10:11Z","timestamp":1723047011263},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To examine whether interleukin-6 in critical coronavirus disease 2019 is higher in arterial than in central venous blood, as a sign of predominantly local pulmonal rather than systemic interleukin-6 production.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Prospective cohort pilot study with repeated weekly measurements of interleukin-6 in arterial and central venous blood. Respiratory function, assessed with Pa<jats:sc>o<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>\/F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> ratio, was measured at the time of blood sampling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>ICU at a university hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SUBJECTS:<\/jats:title>\n            <jats:p>Nine adult patients with critical coronavirus disease 2019, actively treated and receiving mechanical ventilation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>No difference between arterial and central venous interleukin-6 was found. There was a significant negative relationship between interleukin-6 concentration and P\/F ratio in both arterial (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.04) and central venous (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.03) blood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>The absence of an arteriovenous interleukin-6 difference implies that interleukin-6 in critical coronavirus disease 2019 is mainly produced outside the lungs as part of a systemic inflammatory response syndrome and act as a driver of local inflammation and damage in the lungs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000542","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T22:00:53Z","timestamp":1632866453000},"page":"e0542","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?"],"prefix":"10.1097","volume":"3","author":[{"given":"Nikolai Ravn","family":"Aarskog","sequence":"first","affiliation":[{"name":"Department of Acute Medicine, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Christian","family":"Aass","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Cato","family":"Holter","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Oslo University Hospital, Oslo, Norway."},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Rostrup","sequence":"additional","affiliation":[{"name":"Department of Acute Medicine, Oslo University Hospital, Oslo, Norway."},{"name":"Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander Rygh","family":"Holten","sequence":"additional","affiliation":[{"name":"Department of Acute Medicine, Oslo University Hospital, Oslo, Norway."},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease.","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"21697","DOI":"10.1038\/s41598-020-78710-7","article-title":"Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19.","volume":"10","author":"J\u00f8ntvedt J\u00f8rgensen","year":"2020","journal-title":"Sci Rep"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19.","volume":"384","author":"Gordon","year":"2021","journal-title":"N Engl J Med"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial.","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1164\/ajrccm.155.1.9001289","article-title":"The regional production of cytokines and lactate in sepsis-related multiple organ failure.","volume":"155","author":"Douzinas","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1067\/msy.2001.118094","article-title":"Differences in arterial and mixed venous IL-6 levels: The lungs as a source of cytokine storm in sepsis.","volume":"130","author":"Tyburski","year":"2001","journal-title":"Surgery"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease.","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10787-019-00628-y","article-title":"Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-\u03baB\/JNK: A possible role of P-glycoprotein.","volume":"28","author":"Ibrahim","year":"2020","journal-title":"Inflammopharmacology"},{"key":"R9-20240807","article-title":"Ventilatory support for hypoxaemic intensive care patients with COVID-19.","volume":"140","author":"Gundem","year":"2020","journal-title":"Tidsskr Nor Laegeforen"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:05:04Z","timestamp":1723043104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":9,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000542","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2021,9,28]]}}}